metaEvidence - overview


			deaths (OS)	progression or deaths (PFS)	RFS/DFS
la/mBC - HER2 positive - 2nd Line (L2) breast cancer - HER2-positive la/mBC - HER2 positive la/mBC - HER2 positive - 2nd Line (L2)
versus placebo
	neratinib vs. placebo	1	-	-	-